LinkMed: Likvor Receives an Order for CELDA From the University Hospital in Linkoping

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: LinkMed’s (STO:LMED) portfolio company Likvor has received an order for Likvor CELDA™ from the University Hospital in Linköping. With Likvor CELDA™ the clinic will be able to dynamic measure the most important parameters concerning the patients’ cerebrospinal fluid including pressure and flow in a controlled and safe process. Likvor CELDA™ was developed to facilitate greater understanding and enhance diagnosis of normal pressure hydrocephalus (NPH), a condition that is often mistaken for dementia. This is the fourth order for the instrument since it got CE marked.